Choose the Right Topical Carrier For Inflammatory and Allergic Skin Disorders
Topical corticosteroids play a major role in the treatment of many dermatologic conditions. However, successful administration depends upon obtaining an accurate diagnosis, choosing the correct drug, selecting the appropriate vehicle and potency, and the frequency of application.
Modern Medicine – Issue 2 2020
Cut the Itch in Childhood Atopic Dermatitis
Atopic dermatitis is a chronic multifactorial disorder that requires multidisciplinary management. The recent literature confirms that the treatment of itching is a challenge. Children with chronic atopic dermatitis-related itch require a comprehensive treatment approach that addresses the underlying cause of pruritus, as well as symptoms and complications that extend beyond the physical domain.
Modern Medicine – Issue 2 2020
A Proactive Tacrolimus Approach Reduces AD Flares
Atopic dermatitis (AD) is a very common, chronic, inflammatory eczematous skin disease, affecting up to 20% of children in Western Europe and Australia. The prevalence of AD in adults is less well defined, but it is believed that about 40% of childhood cases will continue into adulthood. The morbidity and impact on quality of life of these patients can be very severe and the psychological distress suffered correlates well with the severity of the dermatitis.
Modern Medicine – Issue 5 2019
A Proactive Tacrolimus Approach Reduces AD Flares
Atopic dermatitis (AD) is a very common, chronic, inflammatory eczematous skin disease, affecting up to 20% of children in Western Europe and Australia. The prevalence of AD in adults is less well defined, but it is believed that about 40% of childhood cases will continue into adulthood. The morbidity and impact on quality of life of these patients can be very severe and the psychological distress suffered correlates well with the severity of the dermatitis.
Modern Medicine – Issue 5 2019
Appropriate Burn Care Crucial for Optimal Healing
Burn injuries are indeed among the most challenging wounds to manage. Following a burn injury, the wound healing process, as well as the time required for healing, will basically depend on the thickness of the injured dermis layer. Prompt and appropriate burn care is crucial for optimal healing and final appearance of the scar, since burn depth might dangerously increase if the wound dries or become infected resulting in delayed wound closure.
Modern Medicine – Issue 4 2019
Emollients…the Mainstay of Atopic Dermatitis Treatment
Atopic dermatitis (AD) is a multifactorial chronic inflammatory skin disease characterised by a decreased skin barrier function that is caused by multiple factors.1 Restoration of the skin barrier promotes optimal hydration and prevents the penetration of external agents that cause worsening of atopy symptoms. Emollients are the main treatment for all grades of AD.
Modern Medicine – April/May 2019
Preserve Barrier Function in Atopic Dermatitis
Atopic dermatitis (AD) is a common eczematous skin disorder affecting 2-20% of the general population. AD is characterised by chronic cutaneous inflammation and dry skin with epidermal barrier dysfunction. Intense pruritus is the major and burdensome symptom of AD. Itch induced scratching appears to exacerbate skin inflammation by accelerating cellular damage in the lesional skin. Approximately 80% of AD patients exhibit elevated levels of serum IgE.
Modern Medicine – Dec/Jan 2019
Protect Your Patients, Warm Them Correctly
The benefits of maintaining normothermia are well understood and form an important component of the perioperative process. However, with increasing pressure on hospitals to reduce costs and become more profitable, this treatment modality can take a backseat either because items such as forced air warming blankets are not reimbursed by medical funders or it forms part of the global fee for surgical procedures and is disregarded so as to cut costs.
Modern Medicine – Dec/Jan 2019
A GP’s Guide to Treating Acne – MM1607
Acne needs to be considered as a diagnosis in both children and adults, as well as the common acne in adolescents. Treatment needs to be individualised according to the clinical presentation and psychological needs of the patient. Due to global concern about increasing antibiotic resistance of bacteria, antibiotics should not be prescribed as monotherapy for patients with acne. Patients have to be reviewed every three to six months so acne management can be assessed and medication changed if ineffective. Many patients worry about acne scarring. Early effective management can lessen the risk of permanent scarring.
Modern Medicine – July 2016
Novel Treatment for Unresectable Metastatic Melanoma – MM1502
South Africa, according to the South African Melanoma Advisory Board, has one of the highest incidences of melanoma cancers in the world. While melanoma is the most deadly form of skin cancer, a greater insight into the immune system has led to the launch of the immune checkpoint inhibitor, ipilimumab, for the treatment of advanced (unresectable or metastatic) melanoma.
Modern Medicine – February 2015
